Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.
In this Clinical Services Journal article, the topic of innovative decontamination efforts and hand hygiene tools are reviewed to show how they have helped hospitals raise infection control standards during the pandemic. Hospitals across the world saw cases rise while also dealing with unique challenges, whether PPE shortages, supply and staff issues, or finding effective […]
Read MoreFDA AUTHORIZES ECOLAB’S BIOQUELL TECHNOLOGY SYSTEM FOR N95 RESPIRATOR DECONTAMINATION Ecolab’s decontamination technology enables respirator reuse by healthcare personnel to help address shortages ST. PAUL, Minn. – December 18, 2020 – Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources, has received Emergency Use […]
Read MoreBioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity As the world prepares to enter the next phase of the COVID-19 pandemic with the potential relaxation of lockdown restrictions, Bioquell, an Ecolab solution and leading manufacturer of high performance bio-decontamination technology, is utilizing its well-proven […]
Read MoreFollowing the COVID-19 lockdown, environmental monitoring at a major international provider of Biologics Contract Development and Manufacturing Organisations (CDMO) services in Wuhan, China indicated spore contamination in a production room. Despite exhausting all disinfection methods in its records, including the manual application of a sporicide, there was a repeated failure of the EM test standards. […]
Read MoreDuring the COVID-19 pandemic, many hospital wards were temporarily converted to solely treat COVID-19 patients. As these begin to revert back to ‘regular’ non COVID-19 wards, a solution is required to manage the increased potential contamination risk facing the patients admitted to these wards. Our latest case study highlights how Bioquell’s RBDS recently returned an […]
Read MoreAn article recently featured in Labmate discusses how Bioquell’s hydrogen peroxide vapour technology has been previously used to combat viruses similar to COVID-19. It reviews experience Bioquell has with other coronaviruses (such as SARS and MERS-CoV) and emerging pathogens. Importantly, the article states that “surface contamination has been implicated in the transmission of certain viruses, […]
Read More22 pieces of Bioquell equipment are destined for Eastern Europe, where the technology will be deployed across 11 hospitals. The systems will be used to decontaminate hospital rooms following confirmed cases of the novel coronavirus (COVID-19), as well as many other challenging pathogens that continue to persist alongside the current global outbreak. Bioquell’s hydrogen peroxide […]
Read MoreWoojung Bio, the authorised sole distributor of Bioquell in South Korea, has expanded its fleet of decontamination equipment with 8 new Bioquell ProteQ systems to combat the spread of COVID-19 in the country. Currently, Woojung Bio have been using this equipment to provide free decontamination services to help those affected by COVID-19. Decontamination services are […]
Read MoreThe Bioquell office in Singapore is taking the fight to COVID-19 with room bio-decontamination service technicians and equipment being deployed almost daily into 4 hospitals across the private and public sector in the country. Over 20 separate interventions have been made to support the terminal disinfection of isolation rooms and multiple bed wards which have […]
Read MoreA specialist unit at a Singapore hospital has selected multiple Bioquell ProteQ units to help them in their fight against COVID-19. They have selected Bioquell due to their past use of the technology in other areas of their hospital and excellent support they have experienced from the local Bioquell team. These additional 4 systems allow […]
Read More